Ischemia Clinical Trials

8 recruiting

Ischemia Trials at a Glance

149 actively recruiting trials for ischemia are listed on ClinicalTrialsFinder across 6 cities in 39 countries. The largest study group is Not Applicable with 55 trials, with the heaviest enrollment activity in New York, Cleveland, and Gainesville. Lead sponsors running ischemia studies include Oslo University Hospital, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, and Assistance Publique - Hôpitaux de Paris.

Treatments under study

About Ischemia Clinical Trials

Looking for clinical trials for Ischemia? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Ischemia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Ischemia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 149 trials

Recruiting
Not Applicable

SELUTION4BTK Trial

Peripheral Arterial DiseaseChronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities
M.A. Med Alliance S.A.376 enrolled48 locationsNCT05055297
Recruiting

A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)

Lower Extremity Acute Limb IschemiaLE ALI
Penumbra Inc.300 enrolled33 locationsNCT06747117
Recruiting

OSA as a Remote Ischemic Preconditioning in Vascular Surgery

Obstructive Sleep ApneaIschemia Reperfusion InjuryVascular Aneurysm
St. Anne's University Hospital Brno, Czech Republic100 enrolled1 locationNCT04630535
Recruiting
Not Applicable

mHealth-CArdiac REhabilitation for INOCA

Ischemia
NYU Langone Health250 enrolled1 locationNCT06829160
Recruiting
Phase 1Phase 2

Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation

Ischemia Reperfusion InjuryDelayed Graft Function
Rhode Island Hospital20 enrolled1 locationNCT04005469
Recruiting

Evaluation of a Diagnostic Software for Coronary Artery Disease Using Retrospective CCTA Data (CODEX-1 Study)

AtherosclerosisMyocardial IschemiaCoronary Artery Disease
Instituto de Investigación Biomédica de Salamanca1,000 enrolled4 locationsNCT06977295
Recruiting
Not Applicable

PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia

Critical Limb Ischemia
LimFlow, Inc.100 enrolled30 locationsNCT05313165
Recruiting
Not Applicable

Speed-up the Diagnosis and Evaluation of anoMalous Coronary ARTery From the Aorta

Myocardial IschemiaSudden Cardiac DeathAAOCA+7 more
IRCCS Policlinico S. Donato38 enrolled1 locationNCT06705751
Recruiting
Not Applicable

Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)

Cardiac Arrest, Out-Of-HospitalHypoxia-Ischemia, BrainHypothermia, Induced
University of Michigan900 enrolled60 locationsNCT05376267
Recruiting
Not Applicable

Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II

Heart FailureCardiovascular DiseasesMyocardial Ischemia+5 more
AliveCor1,000 enrolled4 locationsNCT06271577
Recruiting

Evolution of the Patient's Perception of the Use of the Upper Limb After a Stroke During Intensive Rehabilitation

Upper Limb Ischemia
Grand Hôpital de Charleroi100 enrolled2 locationsNCT06569771
Recruiting
Not Applicable

iCorMicA - Stratified Medicine in Angina

Coronary Microvascular Dysfunction (CMD)Angina, StableMicrovascular Angina+1 more
NHS Greater Glasgow and Clyde1,500 enrolled39 locationsNCT04674449
Recruiting
Not Applicable

COronoary Microcirculation Analysis NETwork

Coronary Artery DiseaseEchocardiographyMicrocirculation Resistance+4 more
Medical University of Bialystok180 enrolled1 locationNCT07498231
Recruiting
Phase 2

Intra-arterial Methylprednisolone After Endovascular Thrombectomy

ThrombectomyIschemia StrokeLarge Vessel Occlusion
Tang-Du Hospital210 enrolled1 locationNCT07516522
Recruiting

Peripheral Extreme Revascularization in "No-option" Patiens With Chronic Limb Threatening Ischemia

Peripheral Arterial DiseaseDiabetic FootCritical Limb-Threatening Ischemia
EndoCore Lab s.r.l.50 enrolled9 locationsNCT06277362
Recruiting

Durg Coated Balloon Angioplasty in Infrapopliteal Lesions

Chronic Limb Threatening IschemiaPeripheral Artery DiseaseArteriosclerosis
Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology1,000 enrolled10 locationsNCT05620095
Recruiting
Phase 2Phase 3

Minocycline in Stroke Study at Maimonides

Cerebrovascular Accident (Stroke)StrokeMortality+4 more
Joyce Chen1,164 enrolled1 locationNCT07237048
Recruiting
Not Applicable

Coeliac Artery Release or Sham Operation

Median Arcuate Ligament SyndromeMesenteric IschemiaDunbar Syndrome+2 more
Medisch Spectrum Twente70 enrolled1 locationNCT05468580
Recruiting

Symptomatic and Systemic Atherosclerotic Plaque Activity in Patients With Peripheral Arterial Disease Using Novel Imaging

Peripheral Arterial DiseaseChronic Limb Threatening Ischemia
University of Edinburgh100 enrolled1 locationNCT07472049
Recruiting
Phase 1

Tocilizumab-aazg for Hemorrhage: Reduction of Ischemic Vascular Events

Delayed Cerebral IschemiaAneurysmal Subarachnoid Hemorrhage
University of Florida30 enrolled1 locationNCT06863480